LIQUID FORMULATIONS OF PROTEINS CONTAINING VISCOSITY-LOWERING AGENTS Russian patent published in 2025 - IPC A61K9/08 A61K39/395 A61K47/12 A61K47/20 A61G3/00 C07K1/14 

Abstract RU 2833959 C2

FIELD: biotechnology.

SUBSTANCE: invention relates to low-viscosity protein compositions. Method of reducing the viscosity of a formulation comprising an antibody comprises a step of combining the antibody, a pharmaceutically acceptable solvent and thiamine or a pharmaceutically acceptable salt thereof, where the formulation contains at least 100 mg/ml of the antibody, from 0.10 M to 0.25 M of thiamine or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable solvent, where the absolute viscosity of the formulation is less than the absolute viscosity of the control formulation containing the antibody and a pharmaceutically acceptable solvent, but without thiamine or a pharmaceutically acceptable salt thereof.

EFFECT: invention provides concentrated low-volume liquid pharmaceutical formulations of proteins with low viscosity.

14 cl, 9 dwg, 40 tbl, 28 ex

Similar patents RU2833959C2

Title Year Author Number
LIQUID COMPOSITIONS OF PROTEINS CONTAINING AGENTS FOR VISCOSITY REDUCTION 2014
  • Larson, Alissa M.
  • Lav, Kevin
  • Uejt, Alisha K.
  • Krejn, Alan
  • Langer, Robert S.
  • Klibanov, Aleksander M.
RU2710542C2
LIQUID PROTEIN COMPOSITIONS CONTAINING VISCOSITY-REDUCING AGENTS 2014
  • Larson, Alissa M.
  • Lav, Kevin
  • Uejt, Alisha K.
  • Krejn, Alan
  • Langer, Robert S.
  • Klibanov, Aleksander M.
RU2782765C2
LIQUID PROTEIN FORMULATIONS CONTAINING IONIC LIQUIDS 2014
  • Uejt Alisha K.
  • Larson Alissa M.
  • Langer Robert S.
  • Klibanov Aleksander M.
  • Lav Kevin
  • Krejn Alan
RU2675824C2
CONCENTRATED PROTEIN PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION 2011
  • Chen Trejsi T.
RU2626512C2
PHARMACEUTICAL FORMULATION CONTAINING BEVACIZUMAB 2021
  • Liu, Mujun
  • Fang, Yuan
  • Han, Dongmei
RU2819797C1
ANTIBODY FORMULATIONS 2012
  • Deshmukkh Adzhaj
  • Zejd Dzhumana
  • Sherer Tomas M.
RU2665810C2
BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR LONG-TERM RELEASE OF PROTEIN 2013
  • Vu Sindi V.
  • Robinson Majkl R.
  • Berk Dzhejms Ej.
  • Khyuz Patrik M.
RU2676102C2
HIGH-CONCENTRATION LIQUID ANTI-EGFR ANTIBODY COMPOSITIONS 2005
  • Mateus Zuzanne
  • Maler Khanns-Kristian
RU2390353C2
SELECTION OF MEDICATIONS FOR LUNG CANCER THERAPY BY MEANS OF ANTIBODY-BASED MATRICES 2008
  • Singkh Sharat
  • Kharvi Zhanna
RU2519647C2
V1A-RECEPTORS AGONISTS 2013
  • Visnevski Kazimezh
  • Kharris Dzheffri S.
  • Galyan Robert Feliks
RU2634617C2

RU 2 833 959 C2

Authors

Larson, Alissa M.

Lav, Kevin

Uejt, Alisha K.

Krejn, Alan

Langer, Robert S.

Klibanov, Aleksander M.

Dates

2025-02-03Published

2022-10-28Filed